neobookRx
DrugsLevel 4 LocalisationS3PDR · ENEEML

Sodium Phosphate

ElectrolyteLaxative

Indications

Registered South African indications:

  • Constipation 
  • Bowel evacuation 

Cautions

Contraindications

  • Hypersensitivity to the active ingredient or any of its excipients
  • Renal impairment (pdr)
  • Appendicitis 
  • Undiagnosed rectal bleeding 
  • Cardiac failure 
  • Bowel obstruction
  • Bowel perforation
  • Congenital megacolon
  • Gastric bypass or bariatric surgery
  • Toxic colitis
  • Toxic megacolon
  • Colostomy
  • Ileostomy
  • Hyperphosphataemia
  • Coadministration with agents that increase serum potassium

Cautions

  • Pregnancy
  • Renal impairment (enema)
  • Elderly 
  • Children
  • Neonates 
  • Unstable angina
  • History of myocardial infarction 
  • Hypertension 
  • Cardiomyopathy 
  • Arrhythmias or risk factors thereof 
  • Pre-existing electrolyte imbalances or risk factors thereof 
  • Dehydration 
  • Gastric retention
  • Gastric hypomotility
  • Ileus
  • Severe chronic constipation
  • Colitis
  • Chronic inflammatory bowel disease
  • Severe active ulcerative colitis
  • Seizure disorder 
  • Bulimia nervosa
  • Debilitated patients 
  • Impaired gag reflex
  • Risk factors or aspiration or regurgitation 
  • High doses
  • Prolonged use
  • Low sodium diet 

Adult dosage

Forms avail. in SA and covered in this monograph: ene, pdr

Constipation

  • Rectal (ene): 135ml, as a single dose

Pre­operative emptying of the bowel

  • Rectal (ene): 135ml, as a single dose
  • Oral (pdr): 1 sachet, 1 day prior to procedure; Then 1 sachet on the day of the procedure

 Ensure adequate clear liquid intake prior to and during bowel evacuation regimens


Lubricate prior to insertion of enema  


When inserting enema, patient should be placed on the left side with knees bent, and should remain in this position until the urge to evacuate is strong (usually within 2-5 minutes)

Paediatric dosage

Forms avail. in SA and covered in this monograph: ene 

Relief of occasional constipation

Younger than 2 years

  • Not established for use

Between 2-4 years

  • Rectal (ene): 32ml, as a single dose

Between 5-12 years

  • Rectal (ene): 64ml, as a single dose

Older than 12 years

  • See adult dosage

Bowel evacuation

Less than 5 years

  • Not established for use

Older than 5 years

  • See adult dosage

 Ensure adequate clear liquid intake prior to and during bowel evacuation regimens


Lubricate prior to insertion of enema  


When inserting enema, patient should be placed on the left side with knees bent, and should remain in this position until the urge to evacuate is strong (usually within 2-5 minutes)

Special populations

Pregnancy

  • Caution
  • Caution should be exercised when administering to pregnant women, as no animal reproductive studies have been conducted

Breastfeeding

  • Compatible
  • Sodium phosphate use is acceptable during breastfeeding. No adverse events are anticipated when used within recommended doses

Renal Impairment

Hepatic Impairment

Elderly

Porphyria Information

Drugs in Sport

  • Permitted - No warnings

Adverse reactions

Central Nervous System Disorders

  • Dizziness
  • Headache
  • Seizures

Cardiovascular Disorders

  • Arrhythmias

Respiratory Disorders

  • Bronchospasm
  • Dyspnoea 

Gastrointestinal Disorders  

  • Bloating
  • Gas formation
  • Nausea and vomiting 
  • Abdominal pain 
  • Cramping 
  • Diarrhoea
  • Ischaemic colitis 
  • Rectal bleeding 

Genitourinary Disorders

  • Acute phosphate nephropathy
  • Nephrolithiasis
  • Acute renal impairment 
  • Renal tubular necrosis

Endocrine and Metabolic Disorders

  • Hyperphosphataemia
  • Hypocalcaemia 
  • Hypokalaemia 
  • Hypernatraemia 
  • Dehydration 
  • Increased thirst 

Skin and Subcutaneous Tissue Disorders

  • Urticaria
  • Rash 

Immune, Blood and Lymphatic System Disorders

  • Anaphylaxis

Interactions

  • Angiotensin-converting enzyme inhibitors 
  • Angiotensin II antagonists
  • Agents that increase serum potassium
  • Antacids
  • Tricyclic antidepressants 
  • Calcium salts 
  • Diuretics 
  • Iron salts 
  • Magnesium salts
  • Multivitamins
  • Minerals
  • Non-steroidal anti-inflammatory drugs
  • Sucralfate

Monitoring

None routine. Specific cases may require

  • Renal function
  • Electrolytes
  • ECG

Mechanism of action

Sodium phosphate exerts its osmotic effect in the small intestine by drawing water into the lumen of the gut, thereby producing distention, peristalsis and evacuation of the bowel.

Dosage forms

  • Powder
  • Enema

Formulation

Monosodium/ Disodium phosphate

Enema (per 150ml) 24g/9g

  • Adco Fosenema (Adcock)

Sodium phosphate/ Sodium biphosphate

Enema (per 100ml) 6g/16g

  • Lenolax Adult (Pharmacare)
  • Lenolax Paediatric (Pharmacare)

Monobasic sodium phosphate/ Dibasic sodium phosphate

Powder (per sachet) 15g/10g

  • Colo-prep (Cipla Medpro)

References

1. https://drive.google.com/drive/folders/0B0xnChtF7vduUk8xeVFxVU1RYm8 (23/07/2010_Adcock_Adco Fosenema_enema) 2. https://drive.google.com/drive/folders/0B0xnChtF7vduUk8xeVFxVU1RYm8 (Pharmacare_Lenolax fleet adult_enema) 3. U2D: Sodium phosphate: Drug information; Uptodate; Downloaded online; 25 Jul 2018 https://www.uptodate.com/contents/sodium-phosphate-drug-information?source=preview&search=sodium%20phosphate&anchor=F221946#F221946 4. http://reference.medscape.com/drug/fleet-enema-pedialax-enema-sodium-phosphate-rectal-999711#6 5. https://drive.google.com/drive/folders/0B0xnChtF7vduUk8xeVFxVU1RYm8 (22/03/2017_Mobimims_Colo-prep_pwd) 6. https://drive.google.com/drive/folders/0B0xnChtF7vduUk8xeVFxVU1RYm8 (15/07/2009_Anmarate_Colo-prep_pwd) 7. NAPOS The Drug Database for Acute Porphyria: Sodium phosphate; Accessed online 30 Oct 2018 http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?atc_code=A06AD17&l=gbr 8. South African Institute for Drug-Free Sport; Lenolax; Accessed online 30 Oct 2018 [http://www.drugfreesport.org.za/online-medication-check/] **No SPC available - SPC for Inj.

Brands & products

4 products · stale NAPPI snapshot · refreshed 5/28/2026 · 159 days old

injectionGeneric· 3 products

from R68.94/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Celestone Injection4 mg/ml1S4R344.68R68.94R120.03713155019
Celestone Injection4 mg/ml1S4R86.89R86.89R41.94713155020
Atg-Fresenius S Anti-Human T-Lymphocyte Globulin (Rabbit)- g5S4R6123.77R1224.75R548.68817244018

sachetGeneric· 1 product

from R145.99/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Colo-prep 25 22g10 g2S3R291.98R145.99R105.53865443009
Trade names (4)
  • Lenolax Adult enema
  • Lenolax Paediatric
  • Colo-prep
  • Adco Fosenema

Medical aid coverage

data not yet integrated
Discovery Health
not yet integrated
  • Comprehensive Series—
  • Executive Plan—
  • KeyCare Series—
  • Priority Series—
  • Saver Series—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Bonitas Medical Fund
not yet integrated
  • BonClassic—
  • BonComprehensive—
  • BonEssential—
  • BonFit Select—
  • BonSave—
  • BonStart—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

GEMS — Government Employees Medical Scheme
not yet integrated
  • Beryl—
  • Emerald—
  • Onyx—
  • Ruby—
  • Sapphire—
  • Tanzanite One—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

POLMED — Police Medical Aid Scheme
not yet integrated
  • Aquarium Option—
  • Efficiency Option—
  • Marine Option—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Interacts with 2 known drugs

Check against other drugs →

Cited in 4 documents

NeoHealth® ID 15343 · updated 11/17/2022